Related Experiment Videos
Pharmacologic therapies in dementia
1Section of Geriatrics, Mayo Clinic Rochester, Minnesota 55905, USA.
Mayo Clinic Proceedings
|November 1, 1995
Summary
Pharmacologic therapies for dementia in elderly patients show limited efficacy and potential adverse effects. Non-drug strategies are preferred for behavioral issues, with careful drug selection crucial for managing cognitive and behavioral problems.
Area of Science:
- Geriatric Medicine
- Neuropharmacology
- Dementia Care
Background:
- Elderly patients with dementia often experience cognitive decline and behavioral disturbances.
- Pharmacologic interventions have been explored to manage these symptoms.
Purpose of the Study:
- To review existing and current pharmacologic treatments for cognitive and behavioral issues in elderly individuals with dementia.
- To assess the efficacy and safety of these drug therapies.
Main Methods:
- A comprehensive survey of the medical literature was conducted.
- Findings on the results of pharmacotherapeutic interventions were detailed.
Main Results:
- Available dementia medications have limitations in efficacy and can cause adverse effects.
- Pharmacologic therapies for behavioral problems in dementia may have limited utility, be harmful, or be effective depending on the situation.
- Psychotropic agent use in nursing homes is federally regulated.
Conclusions:
- Drug therapies for dementia in the elderly are associated with adverse effects.
- Medications for aggressive behaviors in dementia should be a last resort after non-drug strategies fail.
- Thorough evaluation of individual cognitive and behavioral problems is essential for appropriate drug selection in dementia patients.